Participant experiences of therapeutic touch in psilocybin-assisted therapy
OpenAlex – March 21, 2025
Source: OpenAlex
Summary
In **Psychology and Mental Health**, **therapeutic touch** during **psilocybin** therapy for anxiety significantly enhanced the experience for many. Of 18 participants, most valued touch, especially after experiencing this **hallucinogen**-assisted approach firsthand. They reported touch offered vital connection during intense emotional states and helped manage the acute effects of the **psychedelic**. Some even attributed direct therapeutic benefits to it. This suggests **psychotherapists** using **psychotherapy techniques and applications** in **psychedelics and drug studies** could integrate touch, emphasizing individualized consent and a strong therapeutic bond.
Abstract
This study explores therapeutic touch in psychedelic-assisted therapy (PAT) through the longitudinal perspectives of participants (n = 18) within a large clinical trial of psilocybin-assisted therapy for Generalised Anxiety Disorder. Qualitative and descriptive results show diverse preferences and responses to touch utilisation. Most participants valued touch, particularly after experiencing it first-hand within psilocybin dosing sessions. Participants felt that touch offered connection during intense emotional experiences and could be used strategically to manage the intensity of acute psychedelic experiences. Some attributed direct therapeutic effect to touch. A strong therapeutic relationship was essential for effective use of touch. While touch appears to be a useful clinical tool in PAT, we argue that its application should be individualized and embedded within a comprehensive consent process. Further research on safety and therapist training is needed to support the role of touch in PAT.